{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:04:52Z","timestamp":1774123492808,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.12.023","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T10:56:22Z","timestamp":1231412182000},"page":"1192-1200","source":"Crossref","is-referenced-by-count":49,"title":["A multi-valent vaccine approach that elicits broad immunity within an influenza subtype"],"prefix":"10.1016","volume":"27","author":[{"given":"Victor C.","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"McCullers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro1819","article-title":"The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus","volume":"6","author":"Karlsson Hedestam","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.023_bib2","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1128\/JVI.73.6.4813-4822.1999","article-title":"Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles","volume":"73","author":"Crawford","year":"1999","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.023_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","article-title":"Prophylactic human papillomavirus vaccines","volume":"116","author":"Lowy","year":"2006","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.023_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.130.4.821","article-title":"Studies on antigenic competition","volume":"130","author":"Brody","year":"1969","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.023_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CVI.00478-06","article-title":"Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines","volume":"14","author":"Garland","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.023_bib8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1086\/503372","article-title":"Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination","volume":"193","author":"Sun","year":"2006","journal-title":"J Infect Dis"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2008.12.023_bib9","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1016\/j.vaccine.2005.07.008","article-title":"Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV","volume":"23","author":"Zhan","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.023_bib10","first-page":"75","article-title":"FluBlok, a recombinant influenza vaccine","volume":"10","author":"Huber","year":"2008","journal-title":"Curr Opin Mol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.023_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/148.5.775","article-title":"Viral respiratory disease at Lowry Air Force Base in Denver, 1952\u20131982","volume":"148","author":"Meiklejohn","year":"1983","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.023_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2105\/AJPH.37.8.1013","article-title":"Experience with vaccination against influenza in the Spring of 1947: a preliminary report","volume":"37","author":"Francis","year":"1947","journal-title":"Am J Public Health Nations Health"},{"issue":"7401","key":"10.1016\/j.vaccine.2008.12.023_bib13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/bmj.326.7401.1223","article-title":"Preventing and treating influenza","volume":"326","author":"Stohr","year":"2003","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.vaccine.2008.12.023_bib14","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib15","first-page":"345","article-title":"Origin and progress of the 1968\u201369 Hong Kong influenza epidemic","volume":"41","author":"Cockburn","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.023_bib17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/315320","article-title":"The impact of influenza epidemics on hospitalizations","volume":"181","author":"Simonsen","year":"2000","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.023_bib19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/oxfordjournals.molbev.a026057","article-title":"Positive selection on the H3 hemagglutinin gene of human influenza virus A","volume":"16","author":"Bush","year":"1999","journal-title":"Mol Biol Evol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.023_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2006.02421.x","article-title":"Variation and infectivity neutralization in influenza","volume":"119","author":"Knossow","year":"2006","journal-title":"Immunology"},{"issue":"5682","key":"10.1016\/j.vaccine.2008.12.023_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/17460794.1.3.255","article-title":"Influenza mutations: trying to hit a moving target","volume":"1","author":"McCullers","year":"2006","journal-title":"Fut Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.12.023_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.023_bib24","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.12.023_bib25","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/S0264-410X(02)00268-2","article-title":"Eight-plasmid system for rapid generation of influenza virus vaccines","volume":"20","author":"Hoffmann","year":"2002","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2008.12.023_bib26","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1128\/JVI.00769-07","article-title":"N-linked glycosylation attenuates H3N2 influenza viruses","volume":"81","author":"Vigerust","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/JVI.78.2.995-998.2004","article-title":"Imparting temperature sensitivity and attenuation in ferrets to A\/Puerto Rico\/8\/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A\/Ann Arbor\/6\/60","volume":"78","author":"Jin","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.023_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/viro.1997.8580","article-title":"Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site","volume":"233","author":"Matrosovich","year":"1997","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.65.3.347","article-title":"An agglutination-inhibition test proposed as a standard of reference in influenza diagnostic studies; Committee on Standard Serological Procedures in Influenza Studies","volume":"65","year":"1950","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.023_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/500247","article-title":"Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets","volume":"193","author":"Huber","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.023_bib31","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.4049\/jimmunol.178.5.3091","article-title":"Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses","volume":"178","author":"Thomas","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.023_bib32","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.12.023_bib33","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1128\/JVI.73.9.7343-7348.1999","article-title":"Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature","volume":"73","author":"McCullers","year":"1999","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.12.023_bib34","first-page":"179","article-title":"Update: influenza activity\u2014United States, September 30, 2007\u2013February 9, 2008","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.023_bib35","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/JVI.64.6.2860-2865.1990","article-title":"Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season","volume":"64","author":"Kanegae","year":"1990","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.023_bib36","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1128\/JVI.02256-07","article-title":"Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007","volume":"82","author":"Wu","year":"2008","journal-title":"J Virol"},{"issue":"10 Suppl","key":"10.1016\/j.vaccine.2008.12.023_bib37","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/INF.0b013e318168b749","article-title":"Vaccines against pandemic influenza: what can be done before the next pandemic?","volume":"27","author":"Huber","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"5414","key":"10.1016\/j.vaccine.2008.12.023_bib38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/bmj.2.5414.943","article-title":"Polyvalent influenza vaccine in general practice","volume":"2","author":"Blow","year":"1964","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.97.2.235","article-title":"Relative antigenic potency in man of polyvalent influenza virus vaccines containing isolated hemagglutinins or intact viruses","volume":"97","author":"Hennessy","year":"1966","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.12.023_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.200.10.896","article-title":"Vaccination of infants against influenza with polyvalent influenza hemagglutinin","volume":"200","author":"Hennessy","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.12.023_bib41","first-page":"15","article-title":"Acute respiratory infections in children. II. A trial of polyvalent virus vaccine","volume":"90","author":"Laxdal","year":"1964","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.023_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/oxfordjournals.aje.a120795","article-title":"Evaluation of monovalent and polyvalent influenza vaccines during an epidemic of type A2 and B influenza","volume":"87","author":"Maynard","year":"1968","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.023_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/123.4.446","article-title":"Immunization against influenza: rationale and recommendations","volume":"123","author":"Eickhoff","year":"1971","journal-title":"J Infect Dis"},{"issue":"4281","key":"10.1016\/j.vaccine.2008.12.023_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.320661","article-title":"Control of influenza and poliomyelitis with killed virus vaccines","volume":"195","author":"Salk","year":"1977","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib45","first-page":"223","article-title":"A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines","volume":"52","author":"Schild","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.023_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1542\/peds.70.6.982","article-title":"Potential for single high-dose influenza immunization in unprimed children","volume":"70","author":"Gross","year":"1982","journal-title":"Pediatrics"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2008.12.023_bib48","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/infdis\/136.Supplement_3.S475","article-title":"Antibody responses and reactogenicity of graded doses of inactivated influenza A\/New Jersey\/76 whole-virus vaccine in humans","volume":"136","year":"1977","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.023_bib49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/clinids\/5.4.723","article-title":"Summary of clinical trials of inactivated influenza vaccine\u20141978","volume":"5","author":"La Montagne","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.023_bib50","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/clinids\/5.4.748","article-title":"Serologic responses and systemic reactions in adults after vaccination with monovalent A\/USSR\/77 and trivalent A\/USSR\/77, A\/Texas\/77, B\/Hong Kong\/72 influenza vaccines","volume":"5","author":"Quinnan","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2008.12.023_bib51","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1073\/pnas.90.24.11478","article-title":"DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations","volume":"90","author":"Fynan","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.vaccine.2008.12.023_bib52","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.vaccine.2005.08.012","article-title":"Epidermal DNA vaccine for influenza is immunogenic in humans","volume":"24","author":"Drape","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35105075","article-title":"Strategies for designing and optimizing new generation vaccines","volume":"1","author":"Berzofsky","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1568005054201517","article-title":"Application of the polyvalent approach to HIV-1 vaccine development","volume":"5","author":"Hurwitz","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.vaccine.2008.12.023_bib56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2741\/2706","article-title":"HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail","volume":"13","author":"Hurwitz","year":"2008","journal-title":"Front Biosci"},{"issue":"10","key":"10.1016\/j.vaccine.2008.12.023_bib57","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara","volume":"198","author":"Sandstrom","year":"2008","journal-title":"J Infect Dis"},{"issue":"46","key":"10.1016\/j.vaccine.2008.12.023_bib58","first-page":"1217","article-title":"Expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2\u20134 years and other FluMist changes for the 2007\u201308 influenza season","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.inf.0000253053.01151.bd","article-title":"The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality","volume":"26","author":"Manzoli","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib60","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J Pediatr"},{"issue":"20","key":"10.1016\/j.vaccine.2008.12.023_bib61","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.vaccine.2007.02.060","article-title":"Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003\u20132004","volume":"25","author":"Halloran","year":"2007","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2008.12.023_bib62","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/S0264-410X(03)00262-7","article-title":"Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A\/Leningrad\/134\/17\/57","volume":"21","author":"Wareing","year":"2003","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2008.12.023_bib63","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1016\/j.vaccine.2007.10.032","article-title":"Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets","volume":"25","author":"Jin","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jmv.1890260209","article-title":"Analysis of virus and host factors in a study of A\/Peking\/2\/79 (H3N2) cold-adapted vaccine recombinant in which vaccine-associated illness occurred in normal volunteers","volume":"26","author":"Betts","year":"1988","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/IAI.23.2.253-259.1979","article-title":"Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A\/Scotland\/840\/74 and A\/Victoria\/3\/75 cold-adapted recombinants derived from the cold-adapted A\/Ann Arbor\/6\/60 strain","volume":"23","author":"Murphy","year":"1979","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.97.2.177","article-title":"Original antigenic sin in ferrets: the response to sequential infections with influenza viruses","volume":"97","author":"Webster","year":"1966","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.124.3.331","article-title":"Disquisitions of original antigenic sin. I. Evidence in man","volume":"124","author":"Fazekas de","year":"1966","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.124.3.347","article-title":"Disquisitions on original antigenic sin. II. Proof in lower creatures","volume":"124","author":"Fazekas de","year":"1966","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.023_bib69","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4049\/jimmunol.178.2.1030","article-title":"Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus","volume":"178","author":"Powell","year":"2007","journal-title":"J Immunol"},{"issue":"34","key":"10.1016\/j.vaccine.2008.12.023_bib70","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.vaccine.2008.06.012","article-title":"FDA\/NIH\/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10\u201311, 2007","volume":"26","author":"Eichelberger","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.023_bib71","doi-asserted-by":"crossref","first-page":"D41","DOI":"10.1016\/j.vaccine.2008.07.043","article-title":"Correlates of protection: novel generations of influenza vaccines","volume":"26S","author":"Rimmelzwaan","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib72","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.023_bib73","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S0022172400024414","article-title":"A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group","volume":"75","author":"Potter","year":"1975","journal-title":"J Hyg (Lond)"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.023_bib75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/135.3.423","article-title":"Dose\u2013response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine","volume":"135","author":"Potter","year":"1977","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.12.023_bib76","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.4049\/jimmunol.172.9.5553","article-title":"Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity","volume":"172","author":"La Gruta","year":"2004","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T14:40:32Z","timestamp":1684852832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08017477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08017477"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}